Endometrial Cancer

>

Latest News

Retrospective Data Show Real-World Disparities in Black vs White Patients With Endometrioid Endometrial Carcinoma
Retrospective Data Show Real-World Disparities in Black vs White Patients With Endometrioid Endometrial Carcinoma

March 18th 2024

SEER data showed that Black patients endometrioid endometrial carcinoma had higher 5-year cancer-related death rates compared with their White counterparts.

Dostarlimab/Chemo Significantly Improves OS in Advanced Endometrial Cancer
Dostarlimab/Chemo Significantly Improves OS in Advanced Endometrial Cancer

March 16th 2024

Pembrolizumab Combo Yields Survival Benefit in Endometrial Cancer
Pembrolizumab Combo Yields Survival Benefit in Endometrial Cancer

March 16th 2024

Data from the phase 3 RUBY trial support the recommendation for dostarlimab plus chemotherapy for patients with advanced MSI-H/dMMR endometrial cancer.
NICE Recommends Dostarlimab/Chemo for MSI-H/dMMR Endometrial Cancer

March 5th 2024

FDA Grants Priority Review to Pembrolizumab/Chemo in Endometrial Cancer | Image Credit: © freshidea - stock.adobe.com.
FDA Grants Priority Review to Pembrolizumab/Chemo in Endometrial Cancer

February 20th 2024

Video Series
Video Interviews
Podcasts

More News